secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2026-08-19T21:00:13+00:00
Accession:  0001493152-26-039247
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis completes stock option exchange; grants RSUs to execs and directors
----------------------------------------------------------------------------

- Stock Option Exchange effective July 24, 2026: 1,319,394 options cancelled for equivalent RSUs on one-for-one basis.
- From exchange: CEO Brian Carrico 199,188 RSUs; CMO Adrian Miranda 199,106; CRO Thomas Carrico 193,678, vesting immediately.
- On Aug 13, 2026: new RSU grants to CEO 193,329, CFO Timothy Henrichs 141,479, CMO 133,341, CRO 135,906, vesting over 3 years.
- One-time equity awards of 127,120 shares to independent directors on Aug 13, 2026, after comp consultant review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000149315226039247/0001493152-26-039247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000149315226039247/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer